Multicenter Phase I/IIa Study to Assess the Safety and Efficacy of Expanded Allogenic Adipose-derived Stem Cells (eASCs) (Cx601), for Treatment of Complex Perianal Fistulas in Perianal Crohn's Disease.
Phase of Trial: Phase I/II
Latest Information Update: 12 Feb 2015
At a glance
- Drugs CX 601 (Primary)
- Indications Rectal fistula
- Focus Adverse reactions
- 12 Feb 2015 Results were published in a TiGenix media release.
- 22 Sep 2014 New trial record